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Abstract  Complex  cystic  masses  are  deﬁned  as  lesions  composed  of  anechoic  (cystic)  and
echogenic  (solid)  components,  unlike  complicated  cysts,  the  echogenic  ﬂuid  content  of  which
imitates  a  solid  lesion.  Complex  masses  are  classiﬁed  as  ACR4  and  require  histological  veriﬁ-
cation by  percutaneous  biopsy  and/or  surgical  ablation.  The  etiology  is  diverse,  and  can  be
benign or  high  risk  (an  abscess,  hematoma,  fat  necrosis,  ﬁbrocystic  mastopathy,  a  phyllodes
tumor, papilloma)  as  much  as  malignant  (papillary  cancer,  necrotic  cancer,  a  ductal  carcinoma
in situ,  metastases).  The  biopsy  technique  must  be  adapted  to  each  case  and  it  is  often  neces-
sary to  insert  a  coil  during  the  procedure.  Histopathological  correlation  is  essential  to  ensure
that the  samples  are  representative  and  concur  with  the  ultrasound  appearance,  so  as  not  to
fail to  recognize  high  risk  or  malignant  lesions  requiring  appropriate  management.
© 2014  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Cysts  are  by  far  the  most  frequently  encountered  breast  condition  and  are  usually  asymp-
tomatic  and  found  accidentally  while  performing  an  ultrasound  examination.  Cystic  lesions
need  to  be  described  and  classed  according  to  the  BIRADS  lexicon  [1,2]  (Table  1):
• typically  benign,  simple  cysts  (ACR2):  strictly  anechoic  content,  imperceptible  wall,
posterior  acoustic  enhancement;
• probably  benign,  complicated  cysts  (ACR3):  homogeneous  hypoechoic  content  or  with
more  or  less  sloping  ﬂuid/ﬂuid  levels,  imperceptible  wall,  with  or  without  posterior
enhancement;
• complex  cysts  of  indeterminate  nature  (ACR4):  association  of  cystic  and  solid  compo-
nents,  thick  wall  or  internal  septum/septa.
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Table  1  BIRADS  classiﬁcation  of  cystic  lesions.
Category  Description  
Simple  cyst  Imperceptible  wall
Anechoic  content
Posterior  acoustic  enhan
Complicated  cyst Thin  wall
Echogenic  content
Fluid/ﬂuid  level
Posterior  acoustic  enhan
Complex  cystic  mass  Thick  wall  >  0.5  mm
Thick  septa  >  0.5  mm
Intracystic  mass
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The  challenge  for  the  radiologist  is  differentiating
etween  a  complicated  cyst  and  a  complex  cystic  mass.
hen  a  solid  component  is  revealed,  even  if  discreet,  the
esion  comes  into  the  category  ACR4  (PPV  between  2—95%)
ith  a  biopsy  indicated  for  diagnostic  purposes.  Indeed,  the
ates  of  malignancy  reported  in  the  literature  vary  between
3%  and  31%  depending  on  the  paper  [3—5].  The  aim  of
his  article  is  to  describe  how  to  optimize  the  ultrasound
echnique,  the  signs  of  complex  masses,  the  place  of  the
ifferent  techniques  of  percutaneous  biopsy  and  to  examine
he  diagnostic  range  of  complex  masses.
xamination techniques
s  for  any  imaging  examination,  it  is  essential  to  have
vailable  all  the  clinical  and  radiological  data  before  per-
orming  and  interpreting  a  breast  ultrasound  examination.
he  ultrasound  technique  (B  mode)  should  meet  the  follow-
ng  criteria:
linear  probes  of  frequencies  between  7.5  and  20  MHz
(more  often  12—14  MHz)  should  be  used.  The  frequency
must  be  adapted  to  the  breast  volume  and  the  location  of
the  lesion  in  the  breast  (lower  frequency  for  deep  lesions,
high  frequency  for  superﬁcial  lesions);
total  gain  and  TGC  should  be  used  to  obtain  an  adequate
and  homogeneous  signal  from  the  skin  to  the  depth  of  the
pectoral  muscle;
the  focal  zone  must  be  adjusted  in  depth  relative  to  the
lesion;
the  lesion  must  be  analyzed  in  at  least  two  planes:  trans-
verse  and  longitudinal  or  radial  (according  to  the  major
axis  of  the  lactiferous  ducts)  and  anti-radial.
The  use  of  additional  modes  helps  characterize  the
esion;  the  radiologist  needs  to  know  their  main  characteris-
ics  as  well  as  their  respective  advantages  and  disadvantages
n  order  to  make  the  best  use  of  them.
armonic modearmonic  mode  improves  spatial  resolution  and  contrast
f  the  lesion  and  reduces  artefacts  (e.g.  reverberation
rtefacts  from  cyst  walls),  so  that  posterior  ultrasound  mod-
ﬁcations  are  seen  better  [6].
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BIRADS  PPV
cement
2 0
cement
3 <  2%
4  2—95%
ompound mode
ompound  mode  improves  the  signal/noise  ratio  by  reducing
ackground  noise  and  speckle  artifact,  optimizes  analysis
f  the  margin  of  the  lesion  and  the  internal  echostructure
f  masses.  It  also  enables  better  detection  of  intralesional
alciﬁcations  [7].  On  the  other  hand,  posterior  ultrasound
odiﬁcations  are  attenuated  [8].
oppler mode
oppler  mode  (color  and/or  power)  ought  to  be  systematic.
t  provides  elements  guiding  diagnosis:  perilesional  hyper-
mia  if  lesions  are  inﬂammatory  (cysts,  abscesses)  versus
ntralesional  vascularization  indicating  the  solid  nature  of
he  lesion.  In  order  to  obtain  a  good  Doppler  map,  it  will  be
ecessary  to:
work  with  PRF  values  of  around  1000  Hz;
set  ampliﬁcation  just  above  the  noise  threshold;
adjust  the  size  of  the  Doppler  box  in  order  to  increase
sensitivity  and  decrease  ﬂow  artifacts  [9].
Power  Doppler  is  more  sensitive  to  slow  ﬂows  but  is  also
ore  sensitive  to  artifacts  [10]. It  should  be  remembered
hat  the  absence  of  a  Doppler  signal  does  not  mean  that  the
olid  nature  of  a lesion  can  be  excluded.
lastography
his  can  help  characterize  complicated  cysts  by  revealing
he  ﬂuid  component  (trilaminar  or  bull’s  eye  appearance  in
tatic  mode,  signal  void  appearance  in  shear  mode).  In  the
ame  way,  if  the  lesion  is  found  to  be  very  hard,this  will  help
onﬁrm  diagnosis  of  complex  masses  and  guide  percutaneous
iopsies  (improving  the  histological  characterization  of  the
esion)  [11,12].
ltrasound signs of complicated cysts
omplicated  cysts  show  all  the  aspects  of  simple  cysts
xcept  for  the  content,  which  is  ﬁnely  echogenic.  They  may
ave  a  ﬂuid  level  or  internal  echoes  that  correspond  to
ebris  and  which  are  displaced  slowly  with  changes  in  the
atient’s  position.  In  no  case  do  complicated  cysts  contain
 solid  parietal  mass  (Fig.  1).
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echoes  related  to  the  hemorrhage,  and  thus  reveal  the
solid  component.  If  necessary,  ultrasound-guided  ﬁne  needle
aspiration  may  conﬁrm  a  true  intracystic  mass.
Ultrasound classiﬁcation of complex
masses
Berg  et  al.  have  deﬁned  4  categories  of  complex  masses
depending  on  morphological  criteria  [4]:
• cysts  with  a  thick  wall  (≥  0.5  mm);
• cysts  with  thick  internal  septa  (≥  0.5  mm)  (Fig.  3);
• predominantly  cystic  complex  masses  (cystic  components
at  least  50%)  (Fig.  4);
• predominantly  solid  complex  masses  (at  least  50%  solid
components)  including  peripheral  cystic  components
(Fig.  5).
Cysts with a thick wall or internal
septum >  0.5 mm
Benign  conditions
• inﬂammatory  cysts,  more  or  less  ruptured;
• ﬁbrocystic  mastopathy  associated  with  apocrine  meta-
plasia.  This  often  manifests  as  grouping  of  microcysts.Figure 1. Complicated cyst. Well-deﬁned round shape showing a
debris/ﬂuid level.
Assessing  the  mobility  of  the  echogenic  component  and
detecting  ﬂow  by  power  Doppler  can  be  of  help:  if  the
echogenic  component  does  not  move  or  if  no  ﬂow  has  been
detected,  it  is  impossible  to  distinguish  between  a  solid  pari-
etal  mass  and  hemorrhagic  or  inﬂammatory  debris  adhering
to  the  wall  of  the  lesion.  On  the  other  hand,  detecting  a
Doppler  signal  indicates  a  real  parietal  mass.
According  to  Berg  et  al.  (ACRIN  6666  study)  [4], only
12%  of  complicated  cysts  reported  actually  seem  to  be  solid
lesions,  with  a  malignancy  rate  of  0.42%.  They  placed  these
lesions  in  the  ACR3  category  and  recommended  follow-up
at  6  months.  If  the  size  changed  over  6  months  by  >  20%,  a
diagnostic  biopsy  was  indicated  [8,13].
Ultrasound signs of complex masses
The  majority  of  complex  masses  show  posterior  acoustic
enhancement  due  to  the  cystic  component.  The  margin  may
be  macro-  or  microlobulated,  indistinct  or  even  irregular.
Differentiating  an  intracystic  mass  from  an  intraductal  mass
is  not  always  obvious,  although  intraductal  masses  are  usu-
ally  tubular  in  appearance  (Fig.  2a  and  b).  Sometimes
intracystic  hemorrhage  can  mask  the  solid  component  of  a
complex  mass.  Simply  moving  the  patient  into  the  lateral
decubitus  position  may  be  enough  to  displace  the  internal
Figure 3. Type II complex cystic mass. This is a predominantly
cystic mass, with many septa, which are > 0.5 mm thick. Cyst with
hemorrhagic changes.
Figure 2. a: diagram of the development of intraductal and intracystic lesions. Initially the lesion with a solid component gradually ﬁlls
and dilates the lactiferous ducts involved. When there is considerable dilatation the lesion appears as a complex cystic mass; b: tubular
intraductal lesion dilating and ﬁlling the duct (intraductal papilloma).
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Figure 4. a: type III complex mass (intracystic mass) corresponding to a modiﬁed cyst; b: similar appearance in another patient where
power Doppler conﬁrmed the solid character of the parietal bud by detecting the internal vascularization. In this case, it was an intracystic
papillary carcinoma.
A  simple  ﬁne  needle  aspiration  biopsy  will  conﬁrm  the
diagnosis;
• fat  necrosis  may  be  seen  as  an  ultrasound  mass  with  a
thick  wall.  There  is  no  hyperemia  in  the  Doppler  unless
there  is  secondary  inﬂammation.  A  connection  to  the  scar
on  the  skin  may  conﬁrm  this  diagnosis;
• collections  (hematoma,  seroma,  lymphocele):  the  clinical
context  will  provide  information  as  to  whether  traumatic
or  post-operative.  (Fig.  6).  Depending  on  the  clinical  pre-
sentation,  a  ﬁrst  reference  ultrasound  examination  can
be  done  at  4—6  months,  since  certain  images  persist  for
several  months;
• a  breast  abscess  is  suggested  from  the  clinical  examina-
tion  when  faced  with  the  trio  of  fever,  pain,  and  local
hyperemia  with  inﬂammatory  skin  signs,  occurring  clas-
sically  in  a  post-partum,  traumatic  or  surgical  context.
The  associated  risk  factors  are  smoking,  diabetes  and
belonging  to  a  black  race  [14].  In  ultrasound,  it  presents
as  a  complex  mass  with  posterior  enhancement,  and  in
color  Doppler,  as  having  thick  hypervascularized  walls.
Fine  needle  aspiration  biopsy  establishes  the  diagnosis
Figure 5. Type IV complex mass with a solid component of
more than 50%, with small peripheral cystic recesses. Fibrocystic
mastopathy.
and  allows  material  to  be  collected  for  bacteriological
analysis  (Fig.  7a—d);
• juvenile  papillomatosis  may  be  seen  as  a  nodular  image
composed  of  multiple  cysts.  This  is  not  a  papillary  lesion
but  a hyperplastic  epithelial  lesion  which  must  be  surgi-
cally  ablated  (a  high  risk  lesion)  [15];
• a  cystic  breast  lymphangioma  is  a  rare  tumor  belonging
to  the  lymphatic  malformation  group.  It  is  a  multiloc-
ulated  lesion  occurring  in  children,  female  adolescents
and  young  women.  It  grows  slowly.  Fine  needle  aspira-
tion  biopsy  will  reveal  the  presence  of  lymphocytes  in  the
ﬂuid  aspirated.  Biopsy  will  also  ﬁnd  the  presence  of  lym-
phoid  cells  thus  conﬁrming  the  diagnosis.  There  is  no  risk
of  these  lesions  becoming  malignant,  but  nevertheless,
because  of  their  size,  surgical  ablation  is  indicated  [16].
Malignant  conditions
These  diseases  are  classically  highly  proliferative  necrotic
cancers  (poorly  differentiated,  grade  III,  necrotic  invasive
ductal  carcinomas)  (Fig.  8a  and  b).  Nevertheless  their  walls
are  markedly  thicker  and  more  highly  vascularized.  They
are  also  associated  with  suspicious  mammography  signs  such
as  a  mass  with  irregular,  even  spiculated  margins,  and  the
presence  of  microcalciﬁcations  and  very  often  axillary  lym-
phadenopathies  (which  are  better  explored  by  ultrasound).
Figure 6. Complex mass with cystic recesses and ﬁbrin septa.
Organized hematoma.
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Figure 7. a: anechoic, ovoid mass with thick posterior wall. Note the pseudo-image at the upper pole (reverberation artifact): mammary
abscess; b: mammary abscess in another patient: hypoechoic mass, containing ﬁne echoes, thick-walled, hypervascularized with color
Doppler; c: needle aspiration cytology showed the presence, on a hemorrhagic background, of inﬂammatory polynuclear cells; d: favorable
progress under treatment with regression of the abscess.
Figure 8. a: breast ultrasound in a young woman to explore a palpable mass. Two contiguous lesions are visible, one hypoechoic, thick-
ggest
•
•walled with focal thickening, and with heterogeneous contents, su
invasive ductal carcinoma with marked necrosis.
Medullary  cancer  can  also  appear  as  a  thick-walled  cystic
mass  [17].
Predominantly cystic complex masses
Benign  conditions
Differential  diagnoses  include:
• modiﬁed  cysts  with  or  without  mobile  debris  (Fig.  9a—c);
• post-therapeutic  fat  necrosis  revealed  as  a  complex  ultra-sound  mass.  Obviously  the  medical  history  and  correlation
with  the  mammogram  showing  typical  fat  clarity  can
conﬁrm  the  diagnosis  without  needing  a  biopsy  for  typical
cases  (Fig.  10a—c);ing hemorrhage and/or internal necrosis; b: histology showing an
a galactocele  appears  as  a  complex  mass  with  several
ﬂuid/ﬂuid  levels.  This  image  ought  not  to  present  a  prob-
lem  of  diagnosis  given  the  context  of  breast-feeding.
papillary  lesions  (benign  and  atypical  papillomas):  papil-
lomas  occur  at  40  to  50  years  of  age,  while  the  age
range  for  papillary  cancers  appearing  is  63—67  years  [18].
Clinically,  these  lesions  may  be  associated  with  breast
discharges,  either  serous  (more  particularly  in  cases  of
benign  papillomas)  or  brownish/hemorrhagic  (suggesting
rather,  a  malignant  lesion).  Papillomas  develop  in  milk
ducts  which  are  subsequently  obstructed.  They  usually
appear  as  cystic  lesions  with  parietal  nodules  (Fig.  11a).
In  color  Doppler,  intralesional  ﬂow  is  observed  in  the  vas-
cular  stalk  (Fig.  11b).  These  lesions  should  be  biopsied
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Figure 9. a: B mode ultrasonography detected an anechoic lesion with an image of focal parietal thickening; b: no signal was detected
with color Doppler; c: shearwave elasticity image. Signal void appearance concordant with mainly ﬂuid content. The echogenic parietal part
is coded in blue; it is very soft with a value < 30 kPa An ultrasound-guided needle aspiration biopsy (14-gauge) targeted on the echogenic
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Nart revealed a modiﬁed cyst.
(Fig.  11c).  Histological  diagnosis  is  based  on  the  presence
of  proliferation  of  ‘‘ﬁnger-in-glove’’  projections  that  are
edged  by  an  epithelium  and  have  a  ﬁbrovascular  core.
It  is  difﬁcult  to  tell  from  biopsy  fragments  whether  a
papillary  lesion  is  benign,  atypical  or  malignant,  in  situ
or  invasive,  hence  the  need  to  analyze  the  entire  lesion
[19—21].  Papillomas  said  to  be  atypical  show  areas  of
apocrine  metaplasia  and/or  atypical  ductal  hyperplasia
(ADH)  (Fig.  12a—c).  The  risk  of  breast  cancer  associated
with  an  atypical  papilloma  is  similar  to  the  risk  in  patients
who  have  ADH  elsewhere  in  the  breast  (×  4—5).  The  risk  of
breast  cancer  is  higher  (×  7)  in  women  with  multiple  atyp-
ical  papillomas  and  peripheral  papillomas.  Moreover,  the
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igure 10. a: thick-walled complex mass including solid parietal nod
ass where the connection to the cutaneous scar can be clearly seen; c
ecrosis corresponding to the ultrasound image. Biopsy is not indicated 
igure 11. a: complex intracystic mass; b: color Doppler examination
uggestive of a papilloma — a biopsy is indicated; c: histology after the 
evertheless surgical ablation to study the whole of the lesion is recommrisk  of  underestimating  a  papillary  carcinoma  is  8—14%,
hence  surgical  ablation  is  recommended  in  order  to  ana-
lyze  the  histology  of  the  entire  lesion  [22].
alignant  conditions
ncapsulated  intracystic  papillary  carcinoma
ncapsulated  intracystic  papillary  carcinoma  is  a  rare  form
f  cancer,  representing  0.6%  to  1%  of  breast  cancers
23—25].  The  appearance  is  more  heterogeneous  compared
ith  papillomas,  and  often  associated  with  hemorrhagic
hanges  (Fig.  13a).  Fine  needle  aspiration  biopsy  is  inad-
quate  (Fig.  13b).  A  10-G  vacuum-assisted  core  biopsy
ith  a  post-biopsy  marker  is  the  procedure  recommended.
ules: b; in another patient, the appearance of a similar complex
: comparison with mammographic images found typically clear fat
in this case.
 detected a vascular stalk within the solid component. Appearance
biopsy showing a papilloma with no signs of atypia or malignancy.
ended (risk of underestimation).
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IFigure 12. a: type III complex mass with discrete hemorrhagic c
formed; c: histological results showed a sclerosing papilloma with a
Macroscopically,  the  mass  is  friable  or  lumpy  inside  a  cyst
(Fig.  13c).  Microscopically,  it  consists  of  one  or  more  papil-
lary  carcinoma  nodules  surrounded  by  a  thick  ﬁbrous  capsule
(Fig.  13d—e).
A  colloid,  metaplastic  or  mucinous  carcinoma
A  colloid,  metaplastic  or  mucinous  carcinoma  can  also  look
like  an  intracystic  mass  but  such  an  appearance  is  rare.
Predominantly solid complex masses
Benign  conditions
• ﬁbrocystic  mastopathy;
• complex  ﬁbroadenomas:  these  are  ﬁbroadenomas  which,
as  well  as  the  dual  ﬁbrous  and  epithelial  component,  also
present  cysts  larger  than  3  mm,  adenosis,  epithelial  cal-
ciﬁcations  and  apocrine  metaplasia  (Fig.  14a—b);• phyllodes  tumors  with,  in  particular  peripherally,  cystic
slits.  Seventeen  percent  of  phyllodes  tumors  are  observed
with  these  features  [26].  Surgical  ablation  to  study  the
entire  lesion  is  essential  (Fig.  15a—c).
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Figure 13. a: type III complex mass; b: the ﬁrst ultrasound-guided need
exceptional richness of which was the reason for histological veriﬁcation
of marker conﬁrmed the presence of malignant papillary cells; c: mac
friable mass inside a cyst. The post-biopsy coil is visible; d and e: microsc
cribriform. The axes of the papillae are bordered by multistratiﬁed carces; b: vacuum-assisted macrobiopsy with a 10-G system was  per-
ine metaplasia. Surgical ablation recommended.
alignant  conditions
olid  papillary  carcinoma
olid  papillary  carcinoma  can  either  be  a  completely  solid
ass  (sometimes  even  containing  microcalciﬁcations),  or  a
redominantly  solid  complex  mass  (Fig.  16a).  Histologically,
o  clear  papillae  are  observed.  The  underlying  papillary
tructure  is  represented  by  a  network  of  ﬁbrovascular  cores
mong  the  solid  cell  proliferation  (Fig.  16b).
ertain  ductal  carcinomas  in  situ
ertain  ductal  carcinomas  in  situ  exhibit  papillary  growth
haracterized  by  a  ﬁbrovascular  core  bordered  by  a  neoplas-
ic  epithelium.  These  lesions  are  different  from  papilloma
olonized  by  DCIS.  They  may  be  observed  as  complex  masses
ontaining  microcalciﬁcations.
nvasive  ductal  carcinoma
nvasive  ductal  carcinoma,  sometimes  of  high  nuclear  grade
grade  III).  The  importance  of  correlation  with  the  clini-
al  ﬁndings  and  the  mammogram,  as  well  as  systematic
xploration  of  the  axilla  using  ultrasonography  should  not
le aspiration biopsy collected cells with a papillary architecture, the
 despite the absence of suspect cells. A macrobiopsy with insertion
roscopic examination of the ablated tissue showed an indented
opic examination: essentially papillary tumor architecture, focally
inomatous cells with moderate cytonuclear atypia.
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Figure 14. a: type IV round complex mass with essentially peripheral, cystic recesses; b: ultrasound-guided microbiopsy (14G) showing a
ﬁbroadenoma.
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ﬁigure 15. a: type IV round complex mass with essentially periph
umor; c: macroscopically, a solid mass was found in the ablated ti
e  forgotten,  to  avoid  misinterpreting  malignant  lesions.
Fig.  17a  and  b).
nvasive  lobular  carcinoma
nvasive  lobular  carcinoma  may  also  present  this  aspect
Fig.  18a—d).are  malignant  lesions
ther  tumors  also  show  as  complex  masses,  such  as
edullary  mucinous  carcinoma,  metaplastic  carcinomas,
reast  sarcomas  and  metastases,  particularly  melanoma.
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igure 16. Solid papillary carcinoma. a: complex mass with a predom
icrocalciﬁcations can be distinguished; b: histological examination fo
brovascular cores.cystic recesses; b: ultrasound-guided microbiopsy (14G): phyllodes
ith peripheral cystic components.
nterventional diagnostic strategy
ampling techniques
omplex  cystic  masses  are  a  challenge  for  interven-
ional  breast  radiologists  because  the  technical  difﬁculty
s  directly  related  to  the  presence  of  a  ﬂuid  component.
ndeed,  aspiration  of  the  cystic  material  and  its  collapse
uring  biopsies  makes  the  associated  solid  component
mperceptible  or  hardly  perceptible  and  therefore  more
ifﬁcult  to  sample  with  certainty.  The  indications  for  biopsy
ust  be  clear  and  precise,  while  avoiding  unnecessary
inately solid component and irregular margins. Intralesional ﬁne
und a malignant papillary structure surrounded by a network of
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Figure 17. a: young woman consulting for a mass that had recently appeared in the left breast. Ultrasound exploration showed a type
IV complex mass. Given her young age ﬁbrocystic mastopathy was wrongly suggested; b: axillary exploration on the other hand corrected
 node
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uthe diagnostic error since it revealed clearly suspect axillary lymph
node invasion.
procedures.  Correlation  with  the  mammogram  data  and  the
patient’s  history  is  essential  to  avoid  sampling  benign  com-
plex  masses  (hematoma,  fat  necrosis,  galactocele),  where
the  alternative  of  close  monitoring  would  seem  to  be  more
appropriate.
Fine needle aspiration biopsy
For  palpable  complex  masses,  biopsy  procedures  should  be
under  ultrasound  guidance  to  ensure  correct  sampling  of
the  solid  component.  Fine  needle  aspiration  is  indicated  as
the  ﬁrst  interventional  procedure  when  there  is  a  problem
of  diagnosis  between  a  complicated  cyst  and  a  predomi-
nantly  cystic  complex  mass.  If  a  purulent  liquid  is  collected,
bacteriological  analysis  should  be  requested.  If  the  liquid
is  hemorrhagic,  it  should  be  sent  for  cytological  analysis
[27,28].  After  any  ﬁne  needle  aspiration  biopsy,  the  lesion
t
a
f
p
Figure 18. a: type IV complex mass; b: microbiopsy performed with a
inserted; d: histology indicated invasive lobular adenocarcinoma. Prolifer
a scleroelastotic stroma. Marked cytonuclear atypia.s with a focally thickened cortex. It was a grade III IDC with lymph
ust  be  reassessed.  If  there  is  partial  or  complete  collapse
f  the  lesion,  a  post-biopsy  marker  should  be  left  at  the  site
f  the  initial  image  [29].
iopsies
f  a  solid  component  remains  after  ﬁne  needle  aspiration
iopsy,  core  biopsies  should  be  performed  in  the  same
ession;  necrotic  components  of  cancers  may  not  contain
alignant  cells  [30].
Where  there  is  a  proven  solid  component,  core  biopsies
ill  be  performed  in  the  ﬁrst  place  whenever  there  are
nfavorable  signs  (microcalciﬁcations  or  architectural  dis-
ortion)  in  a  mammogram.  For  predominantly  solid  lesions,
 14-gauge  needle  is  perfectly  suitable.  On  the  other  hand,
or  lesions  which  are  predominantly  cystic  and  have  small
arietal  nodules,  a vacuum-assisted  macrobiopsy  system
 14G system; c: because of partial collapse a post-biopsy clip was
ation of independent cells or cells connected in narrow lines within
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[78  
ith  8  or  10-gauge  needles  is  preferable.  If  the  mass  is  asso-
iated  with  calciﬁcations,  an  X-ray  of  the  samples  should  be
aken.  A  post-biopsy  marker  should  always  be  inserted  at
he  end  of  the  procedure  if  the  residual  mass  is  difﬁcult  to
ee  [29].
adiologic/pathologic correlation
adiologic/histopathologic  concordance  must  be  estab-
ished  and  the  lesion  deﬁnitively  classiﬁed  (multidisciplinary
taff).  It  must  therefore  be  possible  to  explain  the  signs
hown  by  each  complex  mass  from  the  histopathological
ata.  The  pathologist  must  have  a  detailed  description  of
he  lesion  to  be  able  to  compare  the  histopathological  with
he  ultrasound  appearance.
f there is concordance
f  there  is  concordance  between  the  imaging  and  the
istopathology,  follow-up  after  6  months  can  be  proposed
efore  returning  to  classic  monitoring,  in  order  to  minimize
he  risks  of  false  negatives  [30].
ny diagnosis of lesions with a risk
ny  diagnosis  of  lesions  with  a  risk  of  underestimation  (pap-
llary  lesion,  phyllodes  tumor,  atypical  ductal  hyperplasia,
n  situ  nodular  neoplasia)  requires  surgical  ablation;  the  rate
f  malignancy  found  on  ablated  tissue  varies  between  30%
nd  38%  [31—33].  The  risk  of  underestimating  the  malig-
ancy  of  papillary  lesions  is  between  8%  and  14%  [22,34]  and
his  is  all  the  greater  when  the  papillomas  are  peripheral
compared  with  centrally  located  papillomas,  i.e.  retroare-
lar).
f there is discordance
f  there  is  discordance,  the  whole  case  should  be
eexamined:  correct  targeting,  representativeness  of  the
amples.  If  necessary  new  percutaneous  biopsies  or  a  sur-
ical  biopsy  will  be  discussed.
onclusion
omplex  cystic  masses  are  lesions  of  an  indeterminate
ature,  classiﬁed  at  least  as  ACR4  and  requiring  percu-
aneous  biopsy  and/or  surgical  ablation.  Ultrasonography
nder  good  conditions  (correct  adjustment,  use  of  harmonic
nd/or  compound  mode,  Doppler  and  elastography)  can
haracterize  these  lesions  and  guide  biopsies.
There  is  a  wide  range  of  diagnoses,  ranging  from
enign  lesions  (inﬂammatory  and/or  modiﬁed  cyst,  post-
herapeutic  changes,  ﬁbroadenoma)  to  high  risk  or  atypical
esions  (papilloma,  phyllodes  tumor),  or  even  malignant
esions  (intracystic  papillary  or  solid  carcinoma,  necrotic
uctal  carcinoma,  lobular  carcinoma).  With  a  rate  of  malig-
ancy  varying  from  23%  to  31%,  any  complex  lesion  must  be
haracterized  and  carefully  sampled.  Papillomas  and  high
isk  lesions  must  be  surgically  ablated.
[
[A.  Athanasiou  et  al.
TAKE-HOME  MESSAGES
• Complex  masses  are  classiﬁed  as  ACR4.
• They  require  histological  veriﬁcation.
• Radiologic/pathologic  correlation  is  essential
(representativeness  of  the  samples,  suitable
management).
• The  rate  of  malignancy  varies  between  23  and  31%.
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